Dr. Singkome Tima is a lecturer and a member of the AMS Cancer Research Unit, Faculty of Associated Medical Sciences, CMU. He obtained his Ph.D. in Nanoscience and Nanotechnology from Chiang Mai University (CMU) in 2017. His doctoral research involves the preparation and evaluation of curcumin nanoparticles as a drug delivery system (DDS) for targeted therapy of leukemia. He spent some parts of his thesis research at the School of Pharmacy, the University of Kansas, USA, designing the FLT3-specific peptides and formulating the FLT3-specific curcumin nanoparticles. His research is focused on activities of natural product extracts for cancer treatment, and cancer targeting, especially leukemia, using various types of nanocarrier systems.